Biological Cell Surface Patents (Class 977/716)
  • Patent number: 8138005
    Abstract: Disclosed is a method for fabricating a high-performance field-effect transistor biosensor for diagnosing cancers using micro conductive polymer nanomaterials funtionalized with anti-VEGF aptamer. Disclosed is a high-sensitivity field-effect transistor biosensor for diagnosing cancers using a micro conductive polymer nanomaterial transistor array including a micro polymer nanomaterial transistor array including a channel region provided with a metal source electrode, a metal drain electrode, a gate and micro polymer nanomaterials, and an anti-VEGF aptamer covalently bound to the surface of the micro polymer nanomaterials constituting the channel region of the micro polymer nanomaterials transistor array, to target VEGF (Vascular endothelial growth factor).
    Type: Grant
    Filed: April 23, 2010
    Date of Patent: March 20, 2012
    Assignee: Snu R&DB Foundation
    Inventors: Jyong Sik Jang, Oh Seok Kwon, Seon Joo Park
  • Patent number: 7625718
    Abstract: SVCT2 is consistently expressed at high levels in brain microvessel endothelial cells. Disclosed herein are assays for determining whether a test material/molecule is a substrate for, and/or is actively transported by, the SVCT2 transporter, and therefore a candidate substrate for crossing the blood brain barrier. The assays are useful in screening for therapeutic, cytotoxic or imaging compounds used in the treatment or diagnosis of neurological diseases.
    Type: Grant
    Filed: July 25, 2006
    Date of Patent: December 1, 2009
    Assignee: XenoPort, Inc.
    Inventor: Noa Zerangue